Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Chemical Information and Modeling|March 29, 2021
Multisite Model of Allosterism for the Adenosine A1 ReceptorGiuseppe Deganutti, Kerry Barkan, Graham Ladds, et al.Journal of Medicinal Chemistry|September 11, 2019
Structural Characterization of Agonist Binding to an A3 Adenosine Receptor through Biomolecular Simulations and Mutagenesis ExperimentsDimitrios Stamatis, Panagiotis Lagarias, Kerry Barkan, et al.Bioscience Reports|August 12, 2017
Hyperglycaemia does not affect antigen-specific activation and cytolytic killing by CD8+ T cells in vivoAsha Recino, Kerry Barkan, F Susan Wong, et al.Journal of Chemical Information and Modeling|November 15, 2019
Insights to the Binding of a Selective Adenosine A3 Receptor Antagonist Using Molecular Dynamic Simulations, MM-PBSA and MM-GBSA Free Energy Calculations, and MutagenesisPanagiotis Lagarias, Kerry Barkan, Eva Tzortzini, et al.Biochimica Et Biophysica Acta. Biomembranes|March 4, 2019
Interactions between RAMP2 and CRF receptors: The effect of receptor subtypes, splice variants and cell contextSian Bailey, Matthew Harris, Kerry Barkan, et al.ACS Pharmacology & Translational Science|February 22, 2021
Deciphering the Agonist Binding Mechanism to the Adenosine A1 ReceptorGiuseppe Deganutti, Kerry Barkan, Barbara Preti, et al.Journal of Medicinal Chemistry|October 21, 2022
Discovery and Structure-Activity Relationship Studies of Novel Adenosine A1 Receptor-Selective AgonistsBarbara Preti, Anna Suchankova, Giuseppe Deganutti, et al.Journal of Medicinal Chemistry|September 29, 2022
Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure-Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy CalculationsMargarita Stampelou, Anna Suchankova, Efpraxia Tzortzini, et al.Scientific Reports|November 28, 2020
Pharmacological characterisation of novel adenosine A3 receptor antagonistsKerry Barkan, Panagiotis Lagarias, Margarita Stampelou, et al.Frontiers in Endocrinology|January 31, 2022
The Role of ICL1 and H8 in Class B1 GPCRs; Implications for Receptor ActivationIan Winfield, Kerry Barkan, Sarah Routledge, et al.Pageof 2